Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

novartis vaccines and diagnostics srl, siena, italy via fiorentina 1,, 53100, siena - a/california/7/2009 (h1n1)pdm09- derived strain used nymc x-181; a/victoria/361/2011(h3n2)-like strain used nymc x-223a derived from a/texas/50/2012; b/massachussets/2/2012-like strain used b/massachusetts/2/2012 wild type - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (15+15+15)mcg/0,5ml pf.syr (1 δόση) - a/california/7/2009 (h1n1)pdm09- derived strain used nymc x-181 15mcg; a/victoria/361/2011(h3n2)-like strain used nymc x-223a derived from a/texas/50/2012 15mcg; b/massachussets/2/2012-like strain used b/massachusetts/2/2012 wild type 15mcg - influenza, purified antigen

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sanofi pasteur sa - a/california/7/2009 (h1n1), a/texas/50/2012 (h3n2) b/massachusetts/02/2012 - solution for injection - 8000004241 - a/california/7/2009 (h1n1) - 15 ug; 8000004436 - a/texas/50/2012 (h3n2) - 15 ug; 8000004437 - b/massachusetts/02/2012 - 15 ug - influenza, purified antigen

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

novartis vaccines influenza srl (0000009870) via fiorentina 1, siena, 53100 - a/california/7/2009 (h1n1); a/perth/16/2009 (h3n2); b/brisbane/60/2008 - suspension for injection in pre-filled syringe - 15mcg per strain - a/california/7/2009 (h1n1) (8000004241) 15mcg; a/perth/16/2009 (h3n2) (8000004243) 15mcg; b/brisbane/60/2008 (8000004244) 15mcg - influenza, purified antigen

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

seqirus s.r.l., italy (0000011732) via del pozzo 3/a, siena, 53035 - a/guandong-maonan/swl 1536/2019 (h1n1) pdm09 - like strain (a/victoria/2454/2019 ivr-207); a/hong kong/2671/2019 (h3n2) - like strain (a/hong kong/2671/2019 ivr-208); b/washington/02/2019 - like strain (b/victoria/705/2018/bvr-11) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ - (15+15+15) mcg/0,5ml pf.syr (1 δόση) - ineof03026 a/guandong-maonan/swl 1536/2019 (h1n1) pdm09 - like strain (a/victoria/2454/2019 ivr-207) 15.000000 mcg; ineof03028 a/hong kong/2671/2019 (h3n2) - like strain (a/hong kong/2671/2019 ivr-208) 15.000000 mcg; ineof03030 b/washington/02/2019 - like strain (b/victoria/705/2018/bvr-11) 15.000000 mcg - influenza vaccines - influenza vaccines

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

glaxosmithkline(cyprus)ltd, cyprus - Β/shanghai/361/2002-ΣΑΝ ΣΤΈΛΕΧΟΣ a/california/7/2004 (h3n2)-like ΣΤΈΛΕΧΟΣ a/new caledonia/20/99ivr-116 - suspension for injection in pre-filled syringe - 15mcg/dose per influenza strain) - 8000002752 - b/shanghai/361/2002-like strain - 15 mcg; 8000002751 - a/california/7/2004 (h3n2)-like strain - 15 mcg; 8000002054 - a/new caledonia/20/99ivr-116 - 15 mcg - influenza, purified antigen

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

glaxosmithkline aebe - a/california/7/2009 (h1n1) pdm09 (a/christchurch/16/2010, nib-74xp), a/ΧΟΝΓΚ ΚΟΝΓΚ/4801/2014 (h3n2) - like ΣΤΈΛΕΧΟΣ (a/ΧΟΝΓΚ ΚΟΝΓΚ/4801/2014, nymc x-263b), b/brisbane/60/2008-ΣΑΝ ΣΤΈΛΕΧΟΣ (b/brisbane/60/2008) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ - (15+15+15)mcg/0,5ml pf.syr (1δόση) - ineof2492 - a/california/7/2009 (h1n1) pdm09 (a/christchurch/16/2010, nib-74xp) - 15.000000 mcg; ineof2544 - a/hong kong/4801/2014 (h3n2) - like strain (a/hong kong/4801/2014, nymc x-263b) - 15.000000 mcg; ineof02112 - b/brisbane/60/2008-like strain (b/brisbane/60/2008) - 15.000000 mcg - influenza, purified antigen

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - Γρίπη, Ανθρώπινα - γρίπης, αδρανοποιημένο, split ιό ή αντιγόνο επιφανείας - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra πρέπει να χρησιμοποιείται σύμφωνα με τις επίσημες συστάσεις.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - Γρίπη, Ανθρώπινα - Τα εμβόλια της γρίπης, η Γρίπη, ζώντων εξασθενημένων - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. Η χρήση του fluenz tetra πρέπει να βασίζεται σε επίσημες συστάσεις.

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

viatris healthcare limited, ireland damastown industrial park, - dublin - a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022, ivr-238); a/cambodia/e0826360/2020 (h3n2) - like strain a/cambodia/e0826360/2020, ivr-224); b/austria/1359417/2021 - like strain b/austria/1359417/2021, bvr-26); b/phuket/3073/2013-like strain (b/yamagata/16/88 lineage) (b/phuket/3073/2013, wild type) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (15+15+15+15)mcg/0.5ml pf.syr. (1 δόση) - a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022, ivr-238) 15mcg; a/cambodia/e0826360/2020 (h3n2) - like strain a/cambodia/e0826360/2020, ivr-224) 15mcg; b/austria/1359417/2021 - like strain b/austria/1359417/2021, bvr-26) 15mcg; b/phuket/3073/2013-like strain (b/yamagata/16/88 lineage) (b/phuket/3073/2013, wild type) 15mcg - influenza, purified antigen

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

glaxosmithkline biologicals sa, rixensart, belgium rue de l' institut 89,, 1330 rixensart - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2) - like strain a/tasmania/503/2020, ivr-221); b/washington/02/2019 - like strain (b/washington/02/2019, wild type); b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (15+15+15+15)mcg/0,5ml pf.syr (1 δόση) - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215) 15mcg; a/cambodia/e0826360/2020 (h3n2) - like strain a/tasmania/503/2020, ivr-221) 15mcg; b/washington/02/2019 - like strain (b/washington/02/2019, wild type) 15mcg; b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) 15mcg - influenza, purified antigen